ASTA Comments on FDA Request for Information on Gluten Labeling and Cross-Contact in Packaged Foods
In April 2026, ASTA submitted comments in response to the Food and Drug Administration's (FDA) request for information (RFI) on labeling and cross-contact of gluten in packaged foods, which specifically referenced ingredients that can be declared using collective terms, such as spices. ASTA's comments highlight that no spices inherently contain gluten, note that FDA should take a scientific, risk-based approach to unintended gluten presence, and express support for consistency with existing FDA requirements and harmonization with internal standards for gluten labeling.
04/16/2026 at 12:00 am
2
Related Resources
ASTA Comments to FDA on Bioterrorism Act Prior Notice
ASTA issued comments to the Food & Drug Administration (FDA) in May 2004 regarding prior notice of imported food under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002.
ASTA Letter to Senator Durbin in Support of Proposed Food Safety Legislation
ASTA sent a letter to Senator Durbin in March 2009 supporting legislation to reform the food safety system, providing comments on specific provisions included in the bill and offering to work with the Senator's staff on modifications that would facilitate implementation and assure the objectives are met.
